News

Bharatt Chowrira has stepped down from his role as chief executive (CEO) and board member at US biopharma PureTech Health.
US pharma major AstraZeneca today released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...
The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the ...
The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...
On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are ...
Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...
The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...
Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no longer just for rare diseases. The US pharma major is paying $1 billion ...
The number of patent disputes in the Russian pharmaceutical industry has almost doubled in the last several years, while these figures continue to grow these days, The Pharma Letter’s local ...
The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...
Alnylam (Nasdaq: ALNY) has secured expanded UK regulatory approval for Amvuttra (vutrisiran), broadening its indication to include treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults ...
Japanese drugmaker JCR Pharmaceuticals has entered into a joint collaboration, option and license agreement with US biotech Acumen Pharmaceuticals to develop a novel therapeutic candidate for the ...